AU1338292A - Serum calcium depressing factor - Google Patents

Serum calcium depressing factor

Info

Publication number
AU1338292A
AU1338292A AU13382/92A AU1338292A AU1338292A AU 1338292 A AU1338292 A AU 1338292A AU 13382/92 A AU13382/92 A AU 13382/92A AU 1338292 A AU1338292 A AU 1338292A AU 1338292 A AU1338292 A AU 1338292A
Authority
AU
Australia
Prior art keywords
serum calcium
depressing
factor
depressing factor
serum
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU13382/92A
Other languages
English (en)
Inventor
Takeyori Saheki
Yoshito Takaoka
Akito Tomomura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chugai Pharmaceutical Co Ltd
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Publication of AU1338292A publication Critical patent/AU1338292A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Diabetes (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Nutrition Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU13382/92A 1991-03-06 1992-03-03 Serum calcium depressing factor Abandoned AU1338292A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP3040073A JPH04279598A (ja) 1991-03-06 1991-03-06 血清カルシウム降下因子
JP3-40073 1991-03-06

Publications (1)

Publication Number Publication Date
AU1338292A true AU1338292A (en) 1992-10-06

Family

ID=12570754

Family Applications (1)

Application Number Title Priority Date Filing Date
AU13382/92A Abandoned AU1338292A (en) 1991-03-06 1992-03-03 Serum calcium depressing factor

Country Status (4)

Country Link
JP (1) JPH04279598A (ja)
AU (1) AU1338292A (ja)
OA (1) OA09712A (ja)
WO (1) WO1992015615A1 (ja)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5786327A (en) 1993-03-12 1998-07-28 Gensci Regeneration Sciences Inc. Bone stimulating factor, methods of isolating same, and methods of increasing bone growth comprising administering same
EP0768378A4 (en) * 1994-06-24 1998-01-14 Chugai Pharmaceutical Co Ltd DNA ENCODING CALDECRIN AND METHOD FOR PRODUCING CALDECRIN BY MEANS OF THIS DNA
US6352973B1 (en) 1995-06-07 2002-03-05 Osteopharm Inc. Bone stimulating factor
US20090053788A1 (en) 2006-12-28 2009-02-26 Aspion Co., Ltd. Muscular dystrophy drug

Also Published As

Publication number Publication date
WO1992015615A1 (en) 1992-09-17
JPH04279598A (ja) 1992-10-05
OA09712A (en) 1993-08-30

Similar Documents

Publication Publication Date Title
AU4468489A (en) Dispenser
AU6743894A (en) Truss
AU2464892A (en) Assay method
AU3757689A (en) Quick actuating closure
AU629097B2 (en) Nail sustainer
AU2441392A (en) Bicyle pedal
AU619746B2 (en) Electro-shear brake
AU3949089A (en) Periodontium-regenerative materials
AU630377B2 (en) Dispenser
AU2572792A (en) Footwear
AU2274092A (en) Linear accelerator
AU2010992A (en) Novel azabicyclobenzisoquinolines
AU2714592A (en) Latent thiol monomers
AU1462992A (en) Agglutination assay
AU1561188A (en) Dispenser
AU6819090A (en) Odontotherapeutical materials
AU2876792A (en) Lighting
AU1338292A (en) Serum calcium depressing factor
AU2647292A (en) Coldproof shoes
AU3644689A (en) Condensed diazepinones
AU3619289A (en) Polyethylene composition
AU3092592A (en) Pipetter
AU3812989A (en) Dispenser
AU1820692A (en) Novel anti-hiv antibodies
AU2886289A (en) Condensed diazepinones